Finance

Beta
Lists
CNTX:NASDAQ
Context Therapeutics Inc
0,56 US$
-2,78%
(-0,016) 1D
0,58 US$
+3,04% (+0,017)
After hours
Closed: 25 ივნ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNTX...
Open
0,56 US$
High
0,61 US$
Low
0,55 US$
Mkt. cap
51,10 მლნ.
Avg. vol.
2,13 მლნ.
Volume
2,05 მლნ.
52-wk high
3,62 US$
52-wk low
0,55 US$
EPS
-0,42 US$
Beta
1,61
Shares outstanding
91,88 მლნ.
No. of employees
15
Open
0,56 US$
High
0,61 US$
Low
0,55 US$
Mkt. cap
51,10 მლნ.
Avg. vol.
2,13 მლნ.
Volume
2,05 მლნ.
52-wk high
3,62 US$
52-wk low
0,55 US$
EPS
-0,42 US$
Beta
1,61
Shares outstanding
91,88 მლნ.
No. of employees
15
News stories
From sources across the web
Investing.com
Investing.com
·
41 წუთის წინ
Reformation files for IPO on NYSE to expand retail footprint
GuruFocus
GuruFocus
·
40 წუთის წინ
A Look at Nasdaq Inc (NDAQ) After 4.8% Decline -- GF Value $77.4
MarketWatch
MarketWatch
·
1 საათის წინ
The S&P 500 is at a critical crossroads. A break lower could signal more losses ahead.
Investor's Business Daily
Investor's Business Daily
·
2 საათის წინ
Futures: What To Do Amid Mixed Market Signals
About Context Therapeutics Inc
CEO-
Employees15
Founded2015
Headquartersფილადელფია, პენსილვანია, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websitecontexttherapeutics.com
Analyst ratings
Based on 7 analysts giving stock ratings to CNTX in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CNTX in the last 3 months.
Highest
Current 0,56 US$
7,00 US$ (+1 150,00%)
Average
5,67 US$ (+912,50%)
Lowest
4,00 US$ (+614,29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
4,00 US$
+614,3%
06/16/2026
Boris Peaker
JonesTrading
Buy
Reiterated
7,00 US$
+1 150%
06/15/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
06/15/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
6,00 US$
+971,4%
06/15/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
5,00 US$
+792,9%
06/15/2026
Biren Amin
Piper Sandler
Buy
Maintained
7,00 US$
+1 150%
06/02/2026
Paul Jeng
Guggenheim
Buy
Maintained
5,00 US$
+792,9%
05/06/2026
Soumit Roy
JonesTrading
Buy
Maintained
7,00 US$
+1 150%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,83 მლნ.
8,72 მლნ.
11,84 მლნ.
7,02 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,93 მლნ.
1,89 მლნ.
1,96 მლნ.
2,33 მლნ.
Operating expense
9,76 მლნ.
10,61 მლნ.
13,80 მლნ.
9,34 მლნ.
Total operating expenses
9,76 მლნ.
10,61 მლნ.
13,80 მლნ.
9,34 მლნ.
Operating income
-9,76 მლნ.
-10,61 მლნ.
-13,80 მლნ.
-9,34 მლნ.
Other non operating income
27,08 ათ.
83,47 ათ.
96,56 ათ.
-
EBT including unusual items
-8,83 მლნ.
-9,69 მლნ.
-13,03 მლნ.
-8,68 მლნ.
EBT excluding unusual items
-8,83 მლნ.
-9,69 მლნ.
-13,03 მლნ.
-8,68 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,83 მლნ.
-9,69 მლნ.
-13,03 მლნ.
-8,68 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,09
-0,10
-0,14
-0,09
Interest and investment income
903,77 ათ.
833,77 ათ.
682,48 ათ.
520,14 ათ.
Interest expense
-
-
-
-
Net interest expenses
903,77 ათ.
833,77 ათ.
682,48 ათ.
520,14 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,75 მლნ.
-10,61 მლნ.
-13,80 მლნ.
-9,34 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CNTX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer